More recently, Foks et al. demonstrated that anti-Tim-3-Ab administration promoted atherosclerotic plaque formation, which indicated that Tim-3-Gal-9 pathway may be concerned with the development of atherosclerosis [36]. The gene discussed is LGALS9; the disease is atherosclerosis.